Speaker
Abstract
Breast cancer screening and diagnosis can save lives through early detection and curative treatments. Continued controversy and publicity arises when potentially life-saving technologies are balanced against epidemiologic and cost-efficacy concerns. Both 2D digital mammography and tomosynthesis (3D) have already established their utility over plain film, while 3D has shown greater cancer detection while reducing unnecessary call-backs. Improved sensitivity and specificity lead to better test perfor-mance and potential cost-efficacy. Current breast ultrasound screening efforts for women with dense breasts have improved cancer detection but still suffer from greater total callbacks and lack of color Doppler and/or elastography to potentially improve specificity. A roadmap thus exists for breast ultrasound tomography to overcome the obstacles necessary to produce a paradigm shift in breast imaging.
